Janus Henderson Group’s BlossomHill Therapeutics BLSM Stock Holding History
Bought
Maintained
Sold
Other funds holding BLSM
Janus Henderson Group's BLSM Position: Q3 2026 in Review
Janus Henderson Group opened a new position in BlossomHill Therapeutics (BLSM) in Q3 2026: 1,336,993 shares worth $24.9M. The stake represents 0.01% of the portfolio and ranks #591 among its holdings.
39 funds tracked by Wall St. Rank hold BLSM as of Q3 2026.
- Janus Henderson Group held 1,336,993 shares of BlossomHill Therapeutics worth $24.9M as of Q3 2026.
- BlossomHill Therapeutics was a new Janus Henderson Group position in Q3 2026.
- BlossomHill Therapeutics made up 0.01% of Janus Henderson Group's portfolio in Q3 2026, its #591 holding.
- 39 funds tracked by Wall St. Rank held BlossomHill Therapeutics as of Q3 2026.
Based on Janus Henderson Group's 13F filing for Q3 2026, filed 16 Nov 2026.